MCL cells overexpress cyclin D1 owing to a t(11;14) chromosomal DNA translocation, although there also exist few MCL cases lacking these biomarkers.1 MCL co-express CD19, CD20 and CD5 antigens with chronic lymphocytic leukemia (CLL), which has many more indolent clinical outcomes, and is typically marked with leukemization. This evidence concerns the gene CCND1 and B-cell chronic lymphocytic leukemia.